Medpace Holdings Inc
NASDAQ:MEDP

Watchlist Manager
Medpace Holdings Inc Logo
Medpace Holdings Inc
NASDAQ:MEDP
Watchlist
Price: 298.55 USD -1.43% Market Closed
Market Cap: 9B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

MEDP Price Targets Summary
Medpace Holdings Inc

Wall Street analysts forecast MEDP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDP is 313.07 USD with a low forecast of 272.7 USD and a high forecast of 424.2 USD.

MEDP Lowest Forecast
Wall Street Target
272.7 USD
9% Downside
MEDP Average Forecast
Wall Street Target
313.07 USD
5% Upside
MEDP Highest Forecast
Wall Street Target
424.2 USD
42% Upside
Lowest
Price Target
272.7 USD
9% Downside
Average
Price Target
313.07 USD
5% Upside
Highest
Price Target
424.2 USD
42% Upside
Medpace Holdings Inc Competitors:
Price Targets
R
RVTY
Revvity Inc
44% Upside
GSS
Genetic Signatures Ltd
143% Upside
WST
West Pharmaceutical Services Inc
33% Upside
T
TEM
Tempus AI Inc
20% Upside
R
RVTY
Revvity Inc
44% Upside
GSS
Genetic Signatures Ltd
143% Upside
WST
West Pharmaceutical Services Inc
33% Upside
T
TEM
Tempus AI Inc
20% Upside
ABSI
Absci Corp
197% Upside
LAB
Standard BioTools Inc
109% Upside
CDXC
Chromadex Corp
19% Upside
W
2268
WuXi XDC Cayman Inc
31% Upside

Revenue
Forecast

Revenue Estimate
Medpace Holdings Inc

For the last 8 years the compound annual growth rate for Medpace Holdings Inc's revenue is 22%. The projected CAGR for the next 3 years is 6%.

22%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Medpace Holdings Inc

For the last 8 years the compound annual growth rate for Medpace Holdings Inc's operating income is 31%. The projected CAGR for the next 3 years is 8%.

31%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Medpace Holdings Inc

For the last 8 years the compound annual growth rate for Medpace Holdings Inc's net income is 53%. The projected CAGR for the next 3 years is 5%.

53%
Past Growth
5%
Estimated Growth
Estimates Accuracy
10%
Average Beat
What are analyst estimates?

See Also

Summary
MEDP intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDP stock valuation using valuation multiples.
Wall Street Estimates
MEDP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MEDP's stock price target?
Price Target
313.07 USD

According to Wall Street analysts, the average 1-year price target for MEDP is 313.07 USD with a low forecast of 272.7 USD and a high forecast of 424.2 USD.

What is Medpace Holdings Inc's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Medpace Holdings Inc's revenue is 22%. The projected CAGR for the next 3 years is 6%.

What is Medpace Holdings Inc's Operating Income forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Medpace Holdings Inc's operating income is 31%. The projected CAGR for the next 3 years is 8%.

What is Medpace Holdings Inc's Net Income forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Medpace Holdings Inc's net income is 53%. The projected CAGR for the next 3 years is 5%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 250,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.